GRN and Alzheimer disease: Also consistent with this possibility, we find that that LSD1 inappropriately mislocalizes to cytoplasmic aggregates of pTau in AD, and global gene expression changes in the degenerating Lsd1CAGG hippocampus correlate with changes in AD and FTD-progranulin cases.